The effects of high dose interferon-β1a on plasma microparticles: Correlation with MRI parameters

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Lowery Nordberg, Mary ^a   Eaton, Erin ^a   Gonzalez Toledo, Eduardo ^c   Harris, Meghan K ^c   Chalamidas, Kathrine ^c   McGee Brown, Jeanie ^c   Ganta, Chaitanya V ^b   Minagar, Alireza ^c   Cousineau, David ^a   Alexander, J Steven ^a,b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Department of Molecular and Cellular Physiology ^*  (United States)

^c Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; CD146 ANTIGEN; CD31 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; BETA INTERFERON;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFECT; DRUG MEGADOSE; DRUG RESPONSE; ENDOTHELIAL MICROPARTICLE; EXPANDED DISABILITY STATUS SCALE; FEMALE; FLOW CYTOMETRY; HUMAN; HYPERTRANSAMINASEMIA; LONG TERM CARE; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSPECTIVE STUDY; THROMBOCYTE POOR PLASMA; THROMBOCYTE RICH PLASMA; BLOOD; DISEASE COURSE; HOSPITALIZATION; IMMUNOLOGY; MEMBRANE MICROPARTICLE; METHODOLOGY; PATHOLOGY; TREATMENT OUTCOME;

ANTIGENS, CD146; ANTIGENS, CD31; CELL-DERIVED MICROPARTICLES; DISEASE PROGRESSION; FLOW CYTOMETRY; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-BETA; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 79955676251     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-43     Document Type: Article

References (22)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000, 343:938-952. 10.1056/NEJM200009283431307, 11006371.
2. Frohman EM, Racke MK, Raine CS. Multiple sclerosis--the plaque and its pathogenesis. N Engl J Med 2006, 354:942-955. 10.1056/NEJMra052130, 16510748.
3. Minagar A, Jy W, Jimenez JJ, et al. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 2001, 56:1319-1324.
4. Brosnan CF, Battistini L, Gao YL, Raine CS, Aquino DA. Heat shock proteins and multiple sclerosis: a review. J Neuropathol Exp Neurol 1996, 55:389-402. 10.1097/00005072-199604000-00001, 8786398.
5. Springer TA. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 1995, 57:827-872. 10.1146/annurev.ph.57.030195.004143, 7778885.
6. Jy W, Minagar A, Jimenez JJ, et al. Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosis. Front Biosci 2004, 9:3137-3144. 10.2741/1466, 15353343.
7. Horstman LL, Jy W, Minagar A, et al. Cell-derived microparticles and exosomes in neuroinflammatory disorders. Int Rev Neurobiol 2007, 79:227-268.
8. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983, 13:227-231. 10.1002/ana.410130302, 6847134.
9. Kuske MD, Johnson JP. Assignment of the human melanoma cell adhesion molecule gene (MCAM) to chromosome 11 band q23.3 by radiation hybrid mapping. Cytogenet Cell Genet 1999, 87:258. 10.1159/000015439, 10702685.
10. Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993, 178:449-460. 10.1084/jem.178.2.449, 2191108, 8340753.
11. Sheremata WA, Jy W, Delgado S, Minagar A, McLarty J, Ahn Y. Interferon-beta1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis. J Neuroinflammation 2006, 3:23. 10.1186/1742-2094-3-23, 1584221, 16952316.
12. Brucklacher-Waldert V, Stuerner K, Kolster M, Wolthausen J, Tolosa E. Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis. Brain 2009, 132:3329-3341. 10.1093/brain/awp289, 19933767.
13. Guezguez B, Vigneron P, Lamerant N, Kieda C, Jaffredo T, Dunon D. Dual role of melanoma cell adhesion molecule (MCAM)/CD146 in lymphocyte endothelium interaction: MCAM/CD146 promotes rolling via microvilli induction in lymphocyte and is an endothelial adhesion receptor. J Immunol 2007, 179:6673-6685.
14. Elshal MF, Khan SS, Takahashi Y, Solomon MA, McCoy JP. CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood. Blood 2005, 106:2923-2924. 10.1182/blood-2005-06-2307, 16204154.
15. Maier CL, Shepherd BR, Yi T, Pober JS. Explant outgrowth, propagation and characterization of human pericytes. Microcirculation 2010, 17:367-380.
16. Langer HF, von der Ruhr JW, Daub K, et al. Capture of endothelial progenitor cells by a bispecific protein/monoclonal antibody molecule induces reendothelialization of vascular lesions. J Mol Med 2010, 88:687-699. 10.1007/s00109-010-0614-5, 20414631.
17. Barisione C, Garibaldi S, Ghigliotti G, et al. CD14CD16 monocyte subset levels in heart failure patients. Dis Markers 2010, 28:115-124.
18. Lawson C, Wolf S. ICAM-1 signaling in endothelial cells. Pharmacol Rep 2009, 61:22-32.
19. Navikas V, He B, Link J, et al. Augmented expression of tumour necrosis factor-alpha and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis. Brain 1996, 119(Pt 1):213-223.
20. Hohnoki K, Inoue A, Koh CS. Elevated serum levels of IFN-gamma, IL-4 and TNF-alpha/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage. J Neuroimmunol 1998, 87:27-32. 10.1016/S0165-5728(98)00053-8, 9670842.
21. Hartung HP, Michels M, Reiners K, Seeldrayers P, Archelos JJ, Toyka KV. Soluble ICAM-1 serum levels in multiple sclerosis and viral encephalitis. Neurology 1993, 43:2331-2335.
22. Henninger DD, Panes J, Eppihimer M, et al. Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol 1997, 158:1825-1832.